Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease

Journal of Surgical Research

Volumn 163, Issue 1, 2010, Pages

  Sharma, Bhuvnesh K ^a   Manglik, Vinod ^b   Elias, E George ^a  

^a Franklin Square Hospital Center   (United States)

^b ELIZABETH CITY STATE UNIVERSITY   (United States)

Author keywords

human cutaneous melanoma; stem cell markers

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD133 ANTIGEN; CELL MARKER; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 5; NESTIN;

ANAMNESIS; ARTICLE; CANCER STAGING; CANCER THERAPY; DISTANT METASTASIS; HEREDITY; HUMAN; HUMAN TISSUE; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; NEURAL STEM CELL; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE SECTION;

ANTIGENS, CD; DISEASE PROGRESSION; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MELANOMA; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; P-GLYCOPROTEIN; PEPTIDES; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955922562     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.03.043     Document Type: Article

References (19)

1. L. Strizzi, D.E. Abbott, and D.S. Salomon Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma Cell Cycle 7 2008 1931
2. C. Massard, E. Deutsch, and J.C. Soria Tumor stem cell-targeted treatment: Elimination or differentiation Ann Oncol 17 2006 1620
3. S.K. Singh, I.D. Clarke, and M. Terasaki Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821
4. H.D. Hemmati, I. Nakano, and J.A. Lazareff Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci USA 100 2003 15178
5. S.K. Singh, C. Hawkins, and I.D. Clarke Identification of human brain tumor initiating cells Nature 432 2004 396
6. M.F. Clarke, and M. Fuller Stem cells and cancer. Two faces of Eve Cell 124 2006 11111
7. E. Monzani, F. Facchetti, and E. Galmozzi Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential Eur J Cancer 43 2007 935
8. Q. Wang, Z. Chen, and C.Z. Du Cancer stem cell marker CD133+ tumor cells and clinical outcome in rectal cancer Histopathology 55 2009 284
9. T. Schatton, G.F. Murphy, and N.Y. Frank Identification of cells initiating human melanomas Nature 451 2008 345
10. J.M. Grichnik Genomic instability and tumor stem cells J Invest Dermatol 126 2006 1214
11. A.M. La Porta Caterina Drug resistance in melanoma: New perspectives Curr Med Chem 14 2007 1
12. N.Y. Frank, A. Margaryan, and Y. Huang ABCB5- mediated doxorubicin transport and chemoresistance in human malignant melanoma Cancer Res 65 2005 4320
13. L.C. Van kempen, J.J. Van den Oord, and G.N. VanMuijen Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin Am J Pathol 156 2000 769
14. T. Yamane, S. Hayashi, and M. Mizoguchi Derivation of melanocytes from embryonic stem cells in culture Dev Dyn 216 1999 450
15. Y. Kawa, M. Ito, and H. Ono Stem cell factor and/or endothelin-3 dependent immortal melanoblast and melanocytes populations derived from mouse neural crest cells Pigment Cell Res 13 2000 73
16. D.C. Bennett Human melanocytes senescence and melanoma susceptibility genes Oncogene 22 2003 3063
17. M.R. Hussein Genetic pathways to melanoma tumorigenesis J Clin Pathol 57 2004 797
18. J.M. Grichnik, J.A. Burch, and R.D. Schulteis Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 126 2006 142
19. T. Reya, S.J. Morrison, and M.F. Clarke Stem cells, cancer and cancer stem cells Nature 414 2001 105